+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bovine Mastitis Treatment System Market 2024-2028

  • PDF Icon

    Report

  • 159 Pages
  • February 2024
  • Region: Global
  • TechNavio
  • ID: 5940320
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bovine mastitis treatment system market is forecasted to grow by USD 551.33 mn during 2023-2028, accelerating at a CAGR of 5.34% during the forecast period. The report on the bovine mastitis treatment system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of mastitis, growing emphasis on food safety and quality, and integration of PLF technologies with bovine mastitis treatment systems.

The bovine mastitis treatment system market is segmented as below:

By Product

  • Antibiotics
  • Others

By Route Of Administration

  • Intramammary
  • Systemic

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the emergence and adoption of automated detection systems and precision medicine as one of the prime reasons driving the bovine mastitis treatment system market growth during the next few years. Also, rising adoption of non-antibiotic therapies for mastitis management and growing awareness about animal welfare will lead to sizable demand in the market.

The report on the bovine mastitis treatment system market covers the following areas:

  • Bovine mastitis treatment system market sizing
  • Bovine mastitis treatment system market forecast
  • Bovine mastitis treatment system market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bovine mastitis treatment system market vendors that include Advanced Animal Diagnostics, Armenta, Bio-Vet, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., Endovac Animal Health, Forte Healthcare Ltd., HIPRA S A, Huvepharma EOOD, ImmuCell Corp., Merck KGaA, Neogen Corp., Nimrod Veterinary Products Ltd., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, West Way Health, Zoetis Inc., and Thermo Fisher Scientific Inc.. Also, the bovine mastitis treatment system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global bovine mastitis treatment system market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global bovine mastitis treatment system market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Route of Administration Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Antibiotics - Market size and forecast 2023-2028
Exhibit 34: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
6.4 Others - Market size and forecast 2023-2028
Exhibit 38: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 44: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 45: Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
Exhibit 46: Chart on Comparison by Route of Administration
Exhibit 47: Data Table on Comparison by Route of Administration
7.3 Intramammary - Market size and forecast 2023-2028
Exhibit 48: Chart on Intramammary - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Intramammary - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Intramammary - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Intramammary - Year-over-year growth 2023-2028 (%)
7.4 Systemic - Market size and forecast 2023-2028
Exhibit 52: Chart on Systemic - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Systemic - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Systemic - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Systemic - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Route of Administration
Exhibit 56: Market opportunity by Route of Administration ($ million)
Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 India - Market size and forecast 2023-2028
Exhibit 83: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on India - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Advanced Animal Diagnostics
Exhibit 107: Advanced Animal Diagnostics - Overview
Exhibit 108: Advanced Animal Diagnostics - Product / Service
Exhibit 109: Advanced Animal Diagnostics - Key offerings
12.4 Bio-Vet
Exhibit 110: Bio-Vet - Overview
Exhibit 111: Bio-Vet - Product / Service
Exhibit 112: Bio-Vet - Key offerings
12.5 Boehringer Ingelheim International GmbH
Exhibit 113: Boehringer Ingelheim International GmbH - Overview
Exhibit 114: Boehringer Ingelheim International GmbH - Business segments
Exhibit 115: Boehringer Ingelheim International GmbH - Key news
Exhibit 116: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 117: Boehringer Ingelheim International GmbH - Segment focus
12.6 Ceva Sante Animale
Exhibit 118: Ceva Sante Animale - Overview
Exhibit 119: Ceva Sante Animale - Product / Service
Exhibit 120: Ceva Sante Animale - Key offerings
12.7 Elanco Animal Health Inc.
Exhibit 121: Elanco Animal Health Inc. - Overview
Exhibit 122: Elanco Animal Health Inc. - Product / Service
Exhibit 123: Elanco Animal Health Inc. - Key offerings
12.8 Endovac Animal Health
Exhibit 124: Endovac Animal Health - Overview
Exhibit 125: Endovac Animal Health - Product / Service
Exhibit 126: Endovac Animal Health - Key offerings
12.9 HIPRA S A
Exhibit 127: HIPRA S A - Overview
Exhibit 128: HIPRA S A - Product / Service
Exhibit 129: HIPRA S A - Key offerings
12.10 ImmuCell Corp.
Exhibit 130: ImmuCell Corp. - Overview
Exhibit 131: ImmuCell Corp. - Business segments
Exhibit 132: ImmuCell Corp. - Key offerings
Exhibit 133: ImmuCell Corp. - Segment focus
12.11 Merck KGaA
Exhibit 134: Merck KGaA - Overview
Exhibit 135: Merck KGaA - Business segments
Exhibit 136: Merck KGaA - Key news
Exhibit 137: Merck KGaA - Key offerings
Exhibit 138: Merck KGaA - Segment focus
12.12 Nimrod Veterinary Products Ltd.
Exhibit 139: Nimrod Veterinary Products Ltd. - Overview
Exhibit 140: Nimrod Veterinary Products Ltd. - Product / Service
Exhibit 141: Nimrod Veterinary Products Ltd. - Key offerings
12.13 Norbrook Laboratories Ltd.
Exhibit 142: Norbrook Laboratories Ltd. - Overview
Exhibit 143: Norbrook Laboratories Ltd. - Product / Service
Exhibit 144: Norbrook Laboratories Ltd. - Key offerings
12.14 Thermo Fisher Scientific Inc.
Exhibit 145: Thermo Fisher Scientific Inc. - Overview
Exhibit 146: Thermo Fisher Scientific Inc. - Business segments
Exhibit 147: Thermo Fisher Scientific Inc. - Key news
Exhibit 148: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 149: Thermo Fisher Scientific Inc. - Segment focus
12.15 Vetoquinol SA
Exhibit 150: Vetoquinol SA - Overview
Exhibit 151: Vetoquinol SA - Business segments
Exhibit 152: Vetoquinol SA - Key news
Exhibit 153: Vetoquinol SA - Key offerings
Exhibit 154: Vetoquinol SA - Segment focus
12.16 Virbac Group
Exhibit 155: Virbac Group - Overview
Exhibit 156: Virbac Group - Business segments
Exhibit 157: Virbac Group - Key news
Exhibit 158: Virbac Group - Key offerings
Exhibit 159: Virbac Group - Segment focus
12.17 Zoetis Inc.
Exhibit 160: Zoetis Inc. - Overview
Exhibit 161: Zoetis Inc. - Business segments
Exhibit 162: Zoetis Inc. - Key news
Exhibit 163: Zoetis Inc. - Key offerings
Exhibit 164: Zoetis Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global bovine mastitis treatment system market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Product - Market share 2023-2028 (%)
Exhibits 31: Data Table on Product - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Product ($ million)
Exhibits 43: Data Table on Market opportunity by Product ($ million)
Exhibits 44: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 45: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by Route of Administration
Exhibits 47: Data Table on Comparison by Route of Administration
Exhibits 48: Chart on Intramammary - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Intramammary - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Intramammary - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Intramammary - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Systemic - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Systemic - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Systemic - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Systemic - Year-over-year growth 2023-2028 (%)
Exhibits 56: Market opportunity by Route of Administration ($ million)
Exhibits 57: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ million)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 101: Impact of drivers and challenges in 2023 and 2028
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Advanced Animal Diagnostics - Overview
Exhibits 108: Advanced Animal Diagnostics - Product / Service
Exhibits 109: Advanced Animal Diagnostics - Key offerings
Exhibits 110: Bio-Vet - Overview
Exhibits 111: Bio-Vet - Product / Service
Exhibits 112: Bio-Vet - Key offerings
Exhibits 113: Boehringer Ingelheim International GmbH - Overview
Exhibits 114: Boehringer Ingelheim International GmbH - Business segments
Exhibits 115: Boehringer Ingelheim International GmbH - Key news
Exhibits 116: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 117: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 118: Ceva Sante Animale - Overview
Exhibits 119: Ceva Sante Animale - Product / Service
Exhibits 120: Ceva Sante Animale - Key offerings
Exhibits 121: Elanco Animal Health Inc. - Overview
Exhibits 122: Elanco Animal Health Inc. - Product / Service
Exhibits 123: Elanco Animal Health Inc. - Key offerings
Exhibits 124: Endovac Animal Health - Overview
Exhibits 125: Endovac Animal Health - Product / Service
Exhibits 126: Endovac Animal Health - Key offerings
Exhibits 127: HIPRA S A - Overview
Exhibits 128: HIPRA S A - Product / Service
Exhibits 129: HIPRA S A - Key offerings
Exhibits 130: ImmuCell Corp. - Overview
Exhibits 131: ImmuCell Corp. - Business segments
Exhibits 132: ImmuCell Corp. - Key offerings
Exhibits 133: ImmuCell Corp. - Segment focus
Exhibits 134: Merck KGaA - Overview
Exhibits 135: Merck KGaA - Business segments
Exhibits 136: Merck KGaA - Key news
Exhibits 137: Merck KGaA - Key offerings
Exhibits 138: Merck KGaA - Segment focus
Exhibits 139: Nimrod Veterinary Products Ltd. - Overview
Exhibits 140: Nimrod Veterinary Products Ltd. - Product / Service
Exhibits 141: Nimrod Veterinary Products Ltd. - Key offerings
Exhibits 142: Norbrook Laboratories Ltd. - Overview
Exhibits 143: Norbrook Laboratories Ltd. - Product / Service
Exhibits 144: Norbrook Laboratories Ltd. - Key offerings
Exhibits 145: Thermo Fisher Scientific Inc. - Overview
Exhibits 146: Thermo Fisher Scientific Inc. - Business segments
Exhibits 147: Thermo Fisher Scientific Inc. - Key news
Exhibits 148: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 149: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 150: Vetoquinol SA - Overview
Exhibits 151: Vetoquinol SA - Business segments
Exhibits 152: Vetoquinol SA - Key news
Exhibits 153: Vetoquinol SA - Key offerings
Exhibits 154: Vetoquinol SA - Segment focus
Exhibits 155: Virbac Group - Overview
Exhibits 156: Virbac Group - Business segments
Exhibits 157: Virbac Group - Key news
Exhibits 158: Virbac Group - Key offerings
Exhibits 159: Virbac Group - Segment focus
Exhibits 160: Zoetis Inc. - Overview
Exhibits 161: Zoetis Inc. - Business segments
Exhibits 162: Zoetis Inc. - Key news
Exhibits 163: Zoetis Inc. - Key offerings
Exhibits 164: Zoetis Inc. - Segment focus
Exhibits 165: Inclusions checklist
Exhibits 166: Exclusions checklist
Exhibits 167: Currency conversion rates for US$
Exhibits 168: Research methodology
Exhibits 169: Validation techniques employed for market sizing
Exhibits 170: Information sources
Exhibits 171: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global bovine mastitis treatment system market: Advanced Animal Diagnostics, Armenta, Bio-Vet, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., Endovac Animal Health, Forte Healthcare Ltd., HIPRA S A, Huvepharma EOOD, ImmuCell Corp., Merck KGaA, Neogen Corp., Nimrod Veterinary Products Ltd., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, West Way Health, Zoetis Inc., and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is emergence and adoption of automated detection systems and precision medicine.'

According to the report, one of the major drivers for this market is the increasing prevalence of mastitis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Advanced Animal Diagnostics
  • Armenta
  • Bio-Vet
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Inc.
  • Endovac Animal Health
  • Forte Healthcare Ltd.
  • HIPRA S A
  • Huvepharma EOOD
  • ImmuCell Corp.
  • Merck KGaA
  • Neogen Corp.
  • Nimrod Veterinary Products Ltd.
  • Norbrook Laboratories Ltd.
  • Vetoquinol SA
  • Virbac Group
  • West Way Health
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.